29727-65-9

Basic information

• Product Name: H-BETA-ALA-ILE-OH
• Synonyms: ALA-ILE;BETA-ALA-ILE;BETA-ALANYL-L-ISOLEUCINE;L-ALANYL-L-ISOLEUCINE;H-ALA-ILE-OH;H-BETA-ALA-ILE-OH;B-ALANYL-L-ISOLEUCINE
• CAS NO: 29727-65-9
• Molecular Formula: C9H18N2O3
• Molecular Weight: 202.25
• Mol File: 29727-65-9.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 409.7°C at 760 mmHg
• Flash Point: 201.6°C
• Appearance: /
• Density: 1.108g/cm³
• Vapor Pressure: 7.34E-08mmHg at 25°C
• Refractive Index: 1.485
• Storage Temp.: -15°C
• PKA: 3.18±0.10(Predicted)
• CAS DataBase Reference: H-BETA-ALA-ILE-OH(CAS DataBase Reference)
• NIST Chemistry Reference: H-BETA-ALA-ILE-OH(29727-65-9)
• EPA Substance Registry System: H-BETA-ALA-ILE-OH(29727-65-9)

Safety Data

• Hazardous Substances Data: 29727-65-9(Hazardous Substances Data)

Usage

General Description

H-BETA-ALA-ILE-OH, also known as beta-alanyl-L-isoleucine, is a chemical compound composed of beta-alanine, alanine, isoleucine, and hydroxyl group. It is a dipeptide, meaning it is made up of two amino acids joined together by a peptide bond. Beta-alanine is a non-proteinogenic amino acid known for its role in the synthesis of carnosine, a dipeptide found in high concentrations in muscle tissue. Isoleucine is an essential amino acid involved in protein synthesis and energy production. The hydroxyl group is a functional group containing an oxygen atom bonded to a hydrogen atom, often playing a role in the structure and function of organic compounds. H-BETA-ALA-ILE-OH may have potential applications in the field of sports nutrition and muscle health, due to its amino acid composition and molecular structure.

InChI:InChI=1/C9H18N2O3/c1-4-5(2)7(9(13)14)11-8(12)6(3)10/h5-7H,4,10H2,1-3H3,(H,11,12)(H,13,14)/t5?,6-,7-/m0/s1

Upstream product

• 56-41-7 L-alanin 
• 73-32-5 L-isoleucine 

Downstream Products

• 70396-21-3 Boc-Ala-Ile-OH 

Relevant articles and documents

DIPEPTIDE-CONTAINING COMPOSITION FOR ORAL ADMINISTRATION

The present invention provides a composition for oral administration, which comprises at least one kind of dipeptide represented by the formula: ????????X-Y (wherein X represents alanyl, glycyl, arginyl, seryl, α-aspartyl or α-glutamyl, and Y represents valine, leucine or isoleucine), with an object of providing a composition for oral administration which is excellent in nutrition, pharmacological effect and gustation and comprises at least one kind selected from valine, leucine and isoleucine, or providing a composition for oral administration which is excellent in processing characteristics such as solubility and tableting property and comprises at least one kind selected from valine, leucine and isoleucine.

ASYMMETRIC TRANSFORMATION OF AMINO ACIDS IN N-SALICYLIDENE AMINO ACYL-L-ISOLEUCINATOCOPPER(II)

A new asymmetric transformation of amino acids was described.Thus, when N-salicylidene-D-alanyl-, D-phenylalanyl-, or D-phenyl-glycyl-L-isoleucinatocopper(II) was incubated at pH 8.5 and 80 deg C, the resulting mixture at equilibrium contained a complex of L-L-dipeptide in the contents of 63-76percent.The epimerization of dipeptides is based on the enhanced activity of N-terminal amino acids through complex formation.